Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, France, and Ireland. The company primarily develops FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. It also markets three sterile injectable drugs used in the hospital setting, including Akovaz that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia; Bloxiverz, a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery; and Vazculep, a phenylephrine hydrochloride injection indicated for the treatment of clinically important hypotension. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. Show More...
-
Website http://www.avadel.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 9.11 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.37 -0.36 -0.13 -1.69 -2.36 0.96 -1.0 1.63 -2.55 -0.89 -0.56 Dividends USD Payout Ratio % * Shares Mil 24.0 25.0 25.0 25.0 36.0 44.0 41.0 42.0 37.0 37.0 38.0 Book Value Per Share * USD 1.47 1.3 1.22 -0.39 1.0 0.33 0.89 2.45 1.76 -0.72 0.55 Free Cash Flow Per Share * USD -0.37 -0.35 -0.96 -1.04 -0.4 1.25 0.81 -0.35 -2.44 -1.46 Return on Assets % -10.63 -12.18 -3.46 -36.76 -58.46 20.89 -17.93 27.38 -42.97 -19.45 -11.05 Financial Leverage (Average) 2.06 2.33 3.85 7.0 3.17 5.84 2.96 68.45 6.48 Return on Equity % -22.11 -26.55 -10.71 -408.97 87.66 -75.09 106.97 -215.72 -187.48 Return on Invested Capital % -20.78 -24.68 -7.03 -54.99 -69.89 41.85 -72.76 107.27 -84.46 -8.77 Interest Coverage -364.25 -116.56 -66.2 -10.76 -8.74 13.45 -9.09 89.08 -9.66 -2.09 -1.82 Current Ratio 2.34 2.0 1.75 0.83 1.59 3.41 2.9 1.43 3.25 2.29 4.05 Quick Ratio 2.12 1.77 1.55 0.69 1.43 3.25 2.77 1.28 2.97 2.12 3.86 Debt/Equity 0.05 0.07 1.1 3.06 0.010 0.010 41.63 3.91